Purpose: This prospective study aimed to compare titration pressures obtained using three methods-full-night titration (FN-T), split-night titration (SN-T), and home auto-titration (HA-T)- in patients with moderate to severe obstructive sleep apnea (OSA). Additionally, factors contributing to pressure differences relative to FN-T were investigated.
Methods: SN-T was performed on 74 patients suspected of having OSA. Those diagnosed with moderate to severe OSA who completed SN-T underwent HA-T for 2-3 weeks. FN-T was then performed on patients who adhered to HA-T for at least 70% of prescribed nights. Ultimately, 29 patients met the inclusion criteria. Titration pressures from SN-T (SN-TP), HA-T (mean pressure [HA-TPm] and 90th percentile pressure [HA-TP90]), and FN-T (FN-TP) were compared using the Wilcoxon signed-rank test. Patients were classified into pressure disparity and non-disparity groups based on differences between FN-TP and the other methods. Logistic regression analyses were performed to identify factors associated with pressure differences. Baseline characteristics in subgroup analyses were compared using independent -tests or Mann-Whitney tests for continuous variables and Fisher's exact tests for categorical variables.
Results: The titration pressures for SN-TP, FN-TP, HA-TP90, and HA-TPm were 8, 9, 9.6, and 8.1 cm HO, respectively. All pressures correlated significantly with FN-TP (p < 0.05). HA-TP90 was significantly higher than FN-TP (p < 0.05), while FN-TP was higher than SN-TP (p < 0.05), with similar trends observed at the individual level. Nasal septal deviation (odds ratio 16.63, p = 0.018) and high apnea-hypopnea index (odds ratio 1.06, p = 0.027) were identified as predictors of pressure differences.
Conclusion: This study is the first to directly compare multiple titration pressures to standard FN-TP in the same patients. SN-T and HA-T are reliable alternatives to FN-T in moderate to severe OSA, though predictors of significant pressure variance require careful consideration.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11899899 | PMC |
http://dx.doi.org/10.2147/NSS.S487341 | DOI Listing |
Eur Stroke J
March 2025
Institute of Cardiovascular and Metabolic Sciences, University of Glasgow, Glasgow, UK.
Introduction: A better understanding of who will develop dementia can inform patient care. Although MRI offers prognostic insights, access is limited globally, whereas CT-imaging is readily available in acute stroke. We explored the prognostic utility of acute CT-imaging for predicting dementia.
View Article and Find Full Text PDFCancer Med
March 2025
Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Introduction: Distress is common among cancer patients, especially those undergoing surgery. However, no study has systematically analyzed distress trends in this population. The purpose of this study was to systematically review perioperative rates of distress, as well as differences across cancer types, in cancer patients undergoing surgical intervention.
View Article and Find Full Text PDFAppl Med Artif Intell (2024)
February 2025
Center for Advanced Medical Computing and Analysis, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
Head motion is a major source of image artifacts in head computed tomography (CT), degrading the image quality and impacting diagnosis. Image-domain-based motion correction is practical for routine use since it doesn't rely on hard-to-obtain CT projection data. However, existing convolutional neural network (CNN)-based methods tend to over-smooth images, particularly in cases of moderate to severe 3D motion artifacts.
View Article and Find Full Text PDFInt J Chron Obstruct Pulmon Dis
March 2025
Real World Data Analytics, Japan Development, GSK, Tokyo, Japan.
Purpose: Following the relatively recent introduction of single-inhaler triple therapies in Japan, this study compared the effectiveness of switching from multiple-inhaler triple therapy (MITT) to once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) by investigating COPD exacerbations and adherence among patients with chronic obstructive pulmonary disease (COPD) in Japan.
Methods: This retrospective, pre-post cohort study using the Medical Data Vision Co. Ltd database identified patients with ≥1 inpatient diagnosis and/or ≥2 outpatient diagnoses of COPD at age ≥40 years prior to the index date (first/earliest date of single-inhaler FF/UMEC/VI initiation from May 1, 2019-February 28, 2022, following a switch from MITT).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!